<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14190">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02922153</url>
  </required_header>
  <id_info>
    <org_study_id>CP2015-4</org_study_id>
    <nct_id>NCT02922153</nct_id>
  </id_info>
  <brief_title>The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)</brief_title>
  <acronym>FROST</acronym>
  <official_title>The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AtriCure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AtriCure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to assess whether intra-operative intercostal cryoanalgesia using
      the cryoICE® probe (AtriCure®, Inc., 7555 Innovation Way, Mason, Ohio) provides superior
      post-operative analgesic efficacy as compared to current pain management in patients
      undergoing unilateral thoracotomy cardiac procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forced Expiratory Volume (FEV1)</measure>
    <time_frame>48-hours post-surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) pain in the surgical region</measure>
    <time_frame>48-hours post-surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spirometry assessments</measure>
    <time_frame>48-hours post-extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) pain</measure>
    <time_frame>72-, 96- and 120-hours Post-Op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Controlled Analgesia (PCA)</measure>
    <time_frame>24-, 48, -96 and 120-hours Post extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>Through discharge from ICU, on average 48-hours post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events related to the CryoAnalgesia procedure or device</measure>
    <time_frame>30-days post-procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Cryoanalgesia + SOC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cryoanalgesia in Conjunction with Standard of Care. Up to 5 sessions of cryoanalgesia for 120 seconds per session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Institutional SOC for pain management will be followed. The use of local post-operative pain management techniques (i.e., intercostal, peri-vertebral, or any other acceptable method) is permitted for both treatment groups up to 24 hours post-operatively according to institutional standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoanalgesia</intervention_name>
    <description>AtriCure® cryoICE cryo-ablation system</description>
    <arm_group_label>Cryoanalgesia + SOC</arm_group_label>
    <other_name>cryoICE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Institutional SOC for pain management will be followed.</description>
    <arm_group_label>Cryoanalgesia + SOC</arm_group_label>
    <arm_group_label>Standard of Care</arm_group_label>
    <other_name>SOC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing unilateral thoracotomy cardiac procedures

          -  Acceptable surgical candidate, including use of general anesthesia

          -  Willing and able to provide written informed consent

          -  Willing and able to return for scheduled follow-up visits

        Exclusion Criteria:

          -  Cardiac valve surgical procedure via conventional full sternotomy

          -  Procedures that require a posterolateral thoracotomy

          -  Current pregnancy

          -  Current use of prescription opioids

          -  FEV1 &lt; 40% predicted

          -  Documented myocardial infarction within 30 days of signing IC

          -  Documented psychiatric disease

          -  Documented chronic pain syndrome

          -  Documented history of substance abuse

          -  Patient currently enrolled in another research study

          -  Physical or mental condition that could impact assessment of pain

          -  Disqualifying medical condition per investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Lau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>William Beecher</last_name>
    <phone>414-418-7913</phone>
    <email>WBeecher@AtriCure.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathie Bloem, RN</last_name>
      <phone>734-615-6170</phone>
    </contact>
    <investigator>
      <last_name>Steven Bolling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie VanRaemdonck, RN, BSN</last_name>
      <phone>248-551-6059</phone>
      <email>Julie.VanRaemdonck@beaumont.org</email>
    </contact>
    <investigator>
      <last_name>Wei Lau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 30, 2016</lastchanged_date>
  <firstreceived_date>September 26, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CryoAnalgesia</keyword>
  <keyword>Thoracotomy</keyword>
  <keyword>FEV1</keyword>
  <keyword>VAS</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
